71 Protocol from Steve Kirsch (COVID-19 Early Treatment Fund), the speaker on the FDA Conference: Fluvoxamine, Proxalutamide, and Ivermectin: 100% success. (www.skirsch.io) posted 3 years ago by wideawakeuk 3 years ago by wideawakeuk +71 / -0 3 comments share 3 comments share save hide report block hide replies
A pleasure fren.